Raymond James Financial
OMGA

Raymond James Financial’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Raymond James Financial’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,091
Closed -$22.4K – 4998
2024
Q4 		$22.4K Buy
+30,091
New +$30K ﹤0.01% 4712

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Raymond James Financial's OMGA Position: Q1 2025 in Review

Raymond James Financial sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 30,091 shares — an estimated $22.4K sold.

Raymond James Financial first reported a position in OMGA in Q4 2024 and held it in 1 quarter. The position peaked at $22.4K in Q4 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Raymond James Financial reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Raymond James Financial sold 30,091 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $22.4K.
  • Raymond James Financial first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Raymond James Financial's Omega Therapeutics, Inc. Common Stock position peaked at $22.4K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Raymond James Financial's 13F filing for Q1 2025, filed 13 May 2025.